Franklin Resources Inc Veracyte, Inc. Transaction History

Franklin Resources Inc

$313 Billion
Q2 2024

A detailed history of Franklin Resources Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 212,413 shares of VCYT stock, worth $7.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

212,413

Previous 202,966 4.65%

Holding current value

$7.49 Million

Previous $4.5 Million 2.33%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$18.86 - $23.55 $178,170 - $222,476	9,447 Added 4.65%	212,413 $4.6 Million
Q1 2024 May 13, 2024	BUY	$21.0 - $29.1 $3.51 Million - $4.86 Million	167,059 Added 465.25%	202,966 $4.5 Million
Q4 2023 Feb 09, 2024	SELL	$19.72 - $28.68 $8,617 - $12,533	-437 Reduced 1.2%	35,907 $987,000
Q3 2023 Nov 13, 2023	SELL	$22.33 - $29.92 $31,128 - $41,708	-1,394 Reduced 3.69%	36,344 $811,000
Q2 2023 Aug 11, 2023	BUY	$20.96 - $26.99 $790,988 - $1.02 Million	37,738 New	37,738 $961,000
Q1 2022 May 13, 2022	SELL	$21.94 - $42.51 $129,380 - $250,681	-5,897 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$36.09 - $53.79 $212,822 - $317,199	5,897 New	5,897 $243,000
Q1 2021 May 13, 2021	SELL	$44.47 - $81.38 $190,331 - $348,306	-4,280 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$32.49 - $61.88 $139,057 - $264,846	4,280 New	4,280 $209,000
Q4 2019 Feb 12, 2020	SELL	$20.78 - $29.99 $2.1 Million - $3.03 Million	-101,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$23.87 - $30.93 $849,772 - $1.1 Million	35,600 Added 54.43%	101,000 $2.42 Million
Q2 2019 Aug 14, 2019	BUY	$22.1 - $28.56 $890,630 - $1.15 Million	40,300 Added 160.56%	65,400 $1.87 Million
Q1 2019 May 14, 2019	BUY	$12.0 - $25.76 $301,200 - $646,576	25,100 New	25,100 $628,000

Others Institutions Holding VCYT

# of Institutions

254

Shares Held

82.1M

Call Options Held

42.3K

Put Options Held

18.2K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.52B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Veracyte, Inc. Transaction History